%D8%B3%D9%8A%D9%84%D9%88%D8%B3%D9%8A%D8%A8%D9%8A%D9%86Psilocibina%D8%B3%DB%8C%D9%84%D9%88%D8%B3%D8%A7%DB%8C%D8%A8%DB%8C%D9%86%D0%9F%D1%81%D0%B8%D0%BB%D0%BE%D1%86%D0%B8%D0%B1%D0%B8%D0%BDPsilocibinaCategory:PsilocybinPsilocybinPsilocybinPsilocybinPsilocybin%CE%A8%CE%B9%CE%BB%CE%BF%CE%BA%CF%85%CE%B2%CE%AF%CE%BD%CE%B7Category:PsilocybinPsilocybinPsilocibinoPsilocibinaPsilots%C3%BCbiin%D8%B3%DB%8C%D9%84%D9%88%D8%B3%D8%A7%DB%8C%D8%A8%DB%8C%D9%86PsilosybiiniPsilocybine%D7%A4%D7%A1%D7%99%D7%9C%D7%95%D7%A6%D7%99%D7%91%D7%99%D7%9FPsilocibinPszilocibinPsilosibinPsilocibinoPsilocibina%E3%82%B7%E3%83%AD%E3%82%B7%E3%83%93%E3%83%B3%EC%8B%A4%EB%A1%9C%EC%8B%9C%EB%B9%88PsilocibinasPsilocib%C4%ABnsPsilocybinePsilocybinPsylocybinaPsilocibina%D0%9F%D1%81%D0%B8%D0%BB%D0%BE%D1%86%D0%B8%D0%B1%D0%B8%D0%BDPsilocibinPsilocybinPsilocyb%C3%ADnPsilocibinPsilocybin%E0%B9%84%E0%B8%8B%E0%B9%82%E0%B8%A5%E0%B9%84%E0%B8%8B%E0%B8%9A%E0%B8%B4%E0%B8%99
about
Direct Comparison of Altered States of Consciousness Induced by LSD and PsilocybinThe Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionBeyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the SelfClinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of ConceptPsilocybin for Treatment of Obsessive Compulsive DisorderPsilocybin vs Escitalopram for Major Depressive Disorder: Comparative MechanismsEffects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsEffects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy SubjectsEffects of Psilocybin in Post-Traumatic HeadacheProphylactic Effects of Psilocybin on Chronic Cluster HeadachePilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder
P4844
Prediction of psilocybin response in healthy volunteersStudying the Effects of Classic Hallucinogens in the Treatment of Alcoholism: Rationale, Methodology, and Current Research with PsilocybinPsilocybin with psychological support for treatment-resistant depression: an open-label feasibility studyPeak experiences of psilocybin users and non-users.Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.The effect of psilocin on memory acquisition, retrieval, and consolidation in the ratPsilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.Experimental psychiatry. V. Psilocybine, a new psychotogenic drug.The pharmacology of psilocybin.Psilocybin--summary of knowledge and new perspectives.The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungiFunctional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.Role of psilocybin in the treatment of depression.Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.Neuroticism is associated with challenging experiences with psilocybin mushrooms.Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.Potential Therapeutic Effects of Psilocybin.The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance.Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.Effect of Psilocybin on Empathy and Moral Decision-Making.Psychotherapie mit adjuvanter Gabe von serotonergen psychoaktiven Substanzen - Möglichkeiten und HindernissePsilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.[The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].Psilocybin-assisted therapy for anxiety and depression: implications for euthanasia.The role of psychedelics in palliative care reconsidered: A case for psilocybin.Psilocybin for depression and anxiety associated with life-threatening illnesses.Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future.Question-based Drug Development for psilocybin - Authors' reply.Enhanced repertoire of brain dynamical states during the psychedelic experience.The relationships of classic psychedelic use with criminal behavior in the United States adult population.
P921
Q61907376-9B06169D-1577-4D01-9168-EDE8987F9EBFQ62030916-8F7CBC77-E7BA-4E7C-B4DA-00438293F551Q62035440-C09CFDFB-DBF4-4D64-8675-A79FEAE1DDD2Q62041068-A69ACB4D-009F-4A53-B817-B256DFE17010Q63397704-9DB2F685-6F48-4843-B81C-EB92831EFBD3Q63404641-10043588-F129-4F7D-B9E6-21F2D51EFEFAQ63577146-A86356F7-AE40-4B66-97FE-6CE3A8362AB0Q63578790-FA47FCA0-AF58-4322-B07E-105BF6910946Q63584401-76E9EA54-9F6E-47E1-8506-03BFBD013EC8Q86285277-AEA14CB3-780E-4687-A7B0-3DCE7A143B10Q96055984-92B7F4D0-B0CC-4228-B10C-2EE101DB2A6F
P4844
Q21134798-cb3eaea1-49c7-dc49-ee8a-0036ac79704bQ22241323-869A0899-CB03-4966-BC31-DD846B20C01BQ28005551-809345DB-577F-4037-A438-82E2EA3B8DCCQ30559498-B38334F8-D4AF-4256-98F7-D4ACE57FC173Q33577499-E6DC9F6F-6220-423C-84A0-8230EF7BBD8FQ33658155-94D50E12-A551-489F-AA61-2FA976A9428FQ34041127-F41A009D-955B-4914-8603-8B7BEFC160EFQ34262546-64A42166-21C6-405E-9BF1-2713F0C7A025Q34272224-A53228EA-313D-415B-9DC6-93AC2CC71007Q34399021-60C21390-2EF1-4AD4-A294-44FBF0A491BEQ34423309-B9A70C1A-5DB3-4833-A6AF-FC23020CFBFEQ36871451-4f0871fb-440d-7b62-44a0-055d9fedb259Q37228293-71909620-DC64-4C47-86D5-3115FCCDDCE4Q37582715-1270F23E-D28D-40B0-95D1-A20CEF907CD7Q37722650-28369B34-82B1-410D-ADBF-5A0EF87ADE58Q38061522-DA1E3C7E-0079-450C-96C6-AA46D39B6D96Q38373370-EE4D5505-65B1-442A-88F1-6F196461AC18Q38378860-1D203BCE-19CF-4A40-BED5-42EE583092DCQ38638190-B1A3DEE9-6248-4E11-8400-CC4C6405EA46Q38645170-5F7F1AE5-D636-44E1-BAE2-993F5E53A23AQ38677356-30291692-33F6-4EED-9E82-4FC60DF43ED5Q38690821-0A398501-1DC2-409D-9341-C6C72D9D08DAQ38741517-3A73516E-BD32-4115-B234-09757C1C709AQ38794300-50D317A7-BED3-4C8B-8266-F871D09449ABQ39079288-BF95B081-B1B8-4ED4-8BE8-04060520522BQ39290453-9B8163BB-9ED7-4675-9D7C-D47CAC3BCB91Q41595312-2C5EDAC3-C2F6-4E3D-A4CC-82237528EE85Q41734504-9CCD98CE-9C49-49A6-A725-C7A738EDA9D5Q42377130-1D6A5CE5-B74D-4E0A-A6BD-287851C842F7Q43842099-1D164AB4-A3ED-474D-98D1-F2B49D581C9CQ43842157-98915FBD-6E9E-489A-9589-75CAD454B179Q43842163-8E0C2842-6811-4E57-8F4A-80B4E6D1F712Q44669726-9EBCB67B-052C-4A5C-83A4-C1C3A2289724Q47767294-77057897-7CD0-469E-B342-8C4AD3E2BC44Q47862941-18EBD3D9-6AA8-4F2E-94DC-8C279D68F780Q47862978-15EC90EB-0427-4B5A-B5A0-CC9689AA85BCQ48023125-9D89D5DA-F4F8-4D1F-9FB9-A0EB1823BE5FQ48547069-058E5E65-7A93-4ED1-8436-B0271447668FQ48681633-7191DAA0-9DD0-4F00-85FA-3CDF4B35E2F0Q50078290-352BBF77-6412-436D-AAC3-6EA96790A35B
P921
description
Jarduera psikikoa estimulatzen ...... 100 aldiz indar gutxiago dute)
@eu
Senyawa kimia
@id
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
name
Psilocibin
@hr
Psilocibin
@sh
Psilocibin
@sr-el
Psilocibina
@ast
Psilocibina
@es
Psilocibina
@it
Psilocibinas
@lt
Psilocibino
@eo
Psilocibino
@io
Psilocybin
@cs
type
label
Psilocibin
@hr
Psilocibin
@sh
Psilocibin
@sr-el
Psilocibina
@ast
Psilocibina
@es
Psilocibina
@it
Psilocibinas
@lt
Psilocibino
@eo
Psilocibino
@io
Psilocybin
@cs
altLabel
3-(2-(Dimethylamino)ethyl)-1H-indol-4-ol dihydrogen phosphate ester
@en
3-(2-Dimethylaminoethyl)indol-4-yl dihydrogen phosphate
@en
4-PO-DMT
@el
4-PO-DMT
@en
4-PO-DMT
@id
4-PO-DMT
@mk
4-PO-DMT
@pl
4-PO-DMT
@sr
4-phosphoryloxy-N,N-dimethyltryptamine
@en
520-52-5
@fr
prefLabel
Psilocibin
@hr
Psilocibin
@sh
Psilocibin
@sr-el
Psilocibina
@ast
Psilocibina
@es
Psilocibina
@it
Psilocibinas
@lt
Psilocibino
@eo
Psilocibino
@io
Psilocybin
@cs